|Publication number||USRE42803 E1|
|Application number||US 11/823,811|
|Publication date||Oct 4, 2011|
|Filing date||Jun 27, 2007|
|Priority date||Nov 10, 1999|
|Also published as||US7037267, USRE46049|
|Publication number||11823811, 823811, US RE42803 E1, US RE42803E1, US-E1-RE42803, USRE42803 E1, USRE42803E1|
|Inventors||David Lipson, Peter Forrest|
|Original Assignee||Koninklijke Philips Electronics N.V.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (35), Non-Patent Citations (12), Referenced by (13), Classifications (28), Legal Events (4)|
|External Links: USPTO, USPTO Assignment, Espacenet|
Notice: More than one reissue application has been filed for the reissue of Pat. No. 7,037,267. The reissue applications are this reissue application Ser. No. 11/823,811 filed Jun. 27, 2007; divisional reissue application Ser. No. 13/204,836 filed Aug. 8, 2011; and divisional reissue application Ser. No. 13/204,984 filed Aug. 8, 2011, all of which are divisional reissues of Pat. No. 7,037,267.
This application claims the benefit of Provisional Application No. 60/164,586 filed Nov. 10, 1999. Friday, Nov. 10, 2000, was a holiday in the District of Columbia; see 35 USC §119(e)(3).
This invention involves medical diagnostic methods, systems, and apparatus, particularly those intended for diagnosis of disorders in the blood supply to the brain.
There are many highly accurate techniques for diagnosing disorders of the brain and nervous system. Unfortunately, many of them require large and immovable equipment, extremely sophisticated computers, and highly trained personnel to operate them. They are not suitable for first responders, paramedics and other field medical personnel. They also are not suitable for the rapid use that medical emergencies require. Similarly, they often are not suitable for use in surgical suites where working room is at a premium, and the large electromagnetic fields generated by some types of equipment are not compatible with other equipment, tools, and personnel typically present.
This document uses a variety of terms from science, engineering, and medicine. Those not specifically defined below have the meanings that they ordinarily have in those fields. The following is a list of specialized terms most commonly used in this document.
Acoustic window (sometimes, acoustic bone window) refers to a portion of the skull that is thin enough to pass ultrasonic waves.
Aneurysms are portions of blood vessels that bulge outward or break open.
Aural refers to the ear or the hearing (auditor) system.
Cerebral, from the medical term cerebellum, refers to the brain.
Cranium is the medical term for the skeleton of the head, also commonly known as the skull.
Clinicians are people trained in medicine, such as physicians, nurses, paramedics, medical technicians, and the like.
Coupling is causing two or more things to work together.
Diagnosis is the act of determining whether a stroke has occurred, and if so what type it is or is not. It includes the process of “differential” diagnosing, which is identifying one type of stroke simultaneously with ruling out the possibility of another type.
Doppler refers to a technique of analyzing waves, in which the change in time of the frequency of waves reflected from an object indicates the speed at which the object is moving toward or from the observer. It is responsible for the familiar effect that the pitch of a sound rises as the object approaches the observer and lowers as the object goes away from the observer.
Emboli are little particles carried by the bloodstream into smaller blood vessels, where they block blood flow to cells beyond. They can be blood clots, bubbles or solids such as plaque. Emboli is the plural of embolus. Embolic refers to a stroke that is caused by an embolus or emboli. Emboli that lodge in place can cause additional thrombi (see below) to form at the same location.
Harmonic refers to a wave having a frequency value that is a multiple of the frequency of some basic wave, called the fundamental (and usually the wave that is directed to an object). Every complicated wave is mathematically equivalent to a collection of the fundamental wave and all the possible harmonic waves, in varying amounts and intensities.
Hemorrhagic, meaning bloody, refers to bleeding. A hemorrhagic stroke is one due to a leakage of the blood supply serving a portion of the brain.
Hertz, abbreviated Hz, is the unit of frequency of a wave, defined as one complete cycle per second.
Imaging is the use of information about an object to determine, by human eye or by a computer, something about the location or condition of the object. It does not require the creation of an actual display of the image that can be seen by a human, because computers (and really smart people) are fully capable of interpreting the various aspects of an image, such as intensity, location, size, etc., as if they were actually viewing a traditional image. An image can be two- or three-dimensional. An image can be fixed in time (sometimes called a static image), like a photograph, or it can be moving in time (sometimes called a dynamic image), like a motion picture.
Ischemic (“without chemicals”) refers to a condition in which tissue does not receive adequate blood supply. An ischemic stroke is caused by a partial or total blockage of the blood supply serving a portion of the brain.
Kilohertz, abbreviated kHz, is a unit of one thousand Hertz.
Microparticulates are very small particles, including microbubbles (“tiny bubbles”), emboli, plaque, and the like.
Nasal refers to the nose.
Neurological refers to the brain and nervous system (the spinal cord and all the nerves).
Nidus is a Latin word for the location of origin of a disease process, such as the point where a blood clot first forms even if the clot travels elsewhere before doing damage.
Ocular refers to the eye.
Opening, in the context of a location of a transducer adjacent the skull, includes a natural opening in the skull, a man-made opening in the skull, or an acoustic window through the bones of the skull.
Orbit is the medical term for the eye socket and the bones of the skull that form it.
Patent is a term used in this document to include not just a cited patent itself, but also any other patent issuing from a patent application claiming priority from the cited patent, e.g., a continuation patent, a continuation-in-part patent, a division (sometimes called a divisional) patent, a reissued patent, or an reexamined patent.
PCT is an acronym for the Patent Cooperation Treaty administered by the WIPO (see below).
Perfusion is a medical term for fluid flow over or through an organ, such as the flow of blood through the cerebral vasculature.
Plaque is the term for fatty deposits that build up on the inside of arteries, sometimes breaking loose and flowing through the body.
Stroke is the term for sudden loss of normal blood flow in a portion of the brain.
Temporary ischemic attacks, or TIAs, are temporary blockages of blood flow in the brain that do not last more than 24 hours. They usually do not last more than a few hours. They generally do not cause permanent damage that is easily perceived by the sufferer or observable by others.
Thrombolytic refers to the process of dissolving a thrombus, or the ability to do so.
Thrombi are a kind of early-stage blood clot. The singular of thrombi is thrombus.
Thrombotic refers to a stroke caused when an artery of the brain narrows to a point at which blood begins to clot at the point of narrowing.
tPA (sometimes t-PA) is the abbreviation for tissue plasminogen activator, a “clot busting” drug known to be effective against ischemic strokes.
Transcranial Doppler, or TCD, is a technique for directing ultrasonic waves through the bones of the skull and analyzing the echoes with Doppler techniques.
Transducers are devices that transform one form of energy into another, such as transforming electrical power into ultrasonic waves or vice versa.
Transorbital refers to crossing through the eye socket.
Ultrasound refers to sound waves having frequencies above the range of human hearing, about 20 kHz, depending on the listener's age and previous experience with loud sounds.
Vasculature is the medical term for blood vessels. It includes the arteries that supply fresh blood to tissue, and the veins that carry spent blood away from tissue.
WIPO is an acronym for the World Intellectual Property Organization, an agency of the United Nations that administers an international system for patent applications under the PCT (see above).
The invention represents an entirely new approach to medical diagnostic systems, particularly those used to diagnose stroke. Because of this new approach, the invention can be described in a large number of “embodiments,” none more preferred than any other in terms of scope or importance.
Some embodiments of the invention can be described as a method, i.e., a “recipe” or procedure to achieve a result. Others can be described as a system (i.e., a fully operating machine), some as an assembly (ie., a “kit” or collection that is intended to put together in a particular manner, and which may or may not have been put together yet), and yet others as a combination (i.e., a group of parts or pieces that are capable of operation together, even if some were parts already present and others had to be supplied). Similarly, parts or portions of each of these embodiments can be described as subsystems, submethods, subassemblies, or subcombinations.
In all embodiments, the invention involves diagnosis of stroke in a patient. More specifically, the invention permits diagnosis of whether a stroke has occurred, and if so, what type of stroke it is.
The two most common types of stroke are hemorrhagic and ischemic. One way to determine hemorrhagic stroke is to identify at least one region of relatively diffuse blood flow within the patient's brain, i.e., finding a region in which the blood flow is outside the arteries, spreading between the brain cells. One way to determine ischemic stroke is to identify at least one location of inadequate blood flow within the patient's brain. In this sense, “inadequate” flow is any condition in which causes less blood to flow for any reason, such as when one or more arteries serving the brain have a partial or total, are narrowed or otherwise reduced in size. The blood vessel itself may change shape, or it may be blocked or narrowed.
Other embodiments of the invention use a more sophisticated approach and specifically distinguish between hemorrhagic and ischemic strokes. One way to do this is to identify either type of stroke in any manner that positively rules out the other. One particular way to do this is to form a two-dimensional or there-dimensional image of the brain. Such images (either of which could be fixed in time like a snapshot or moving like a motion picture) can be analyzed by a computer or by a clinician to diagnose not just whether the patient has suffered a stroke, but specifically which kind.
Some embodiments use optional additional techniques to enhance stroke diagnosis. For example, Doppler techniques can be used to form an image of the flow of microparticulates. Hemorrhagic stroke can be identified (and the difference between hemorrhagic and ischemic stroke can be identified) based on the relative flow rates of the microparticulates. In another example, harmonic techniques are used to compare the diffusion (if any) of blood flow between two or more areas of the brain. As noted before, diffuse blood flow indicates that blood is spreading between cells instead of passing normally through the arteries in the vicinity.
In all embodiments, ultrasonic signals are generated and directed into the brain. The ultrasonic waves strike their target, namely the brain tissue, the blood vessels, and the blood itself. Some of the ultrasonic energy is reflected, forming a reflected signal, or echo, from the brain. Different targets produce different echoes. The echoes are received and processed into information that indicates the identity of the target, that is, the condition of the patient's brain.
Information from at least one reflected ultrasonic signal is analyzed to diagnose the patient. This may be accomplished using any convenient method or equipment already known to those skilled in the art of medical ultrasonic diagnosis. In general, the signals are converted into digital data and analyzed by a computer. Either the computer program will diagnose the presence and type of stroke, or it will present the data in any convenient manner so that a clinician may make the diagnosis. For example, the program may produce the two-dimensional or three-dimensional images described earlier.
A single ultrasonic transmitter, or several such transmitters, may be used to generate the ultrasonic signals. A single ultrasonic receiver, or several such receivers, may be used to detect the ultrasonic echoes. It is typical, but not required, for an ultrasonic transmitter and receiver to be combined into a single unit. Therefore, the remainder of this document uses the term transmitter/receiver with the understanding that the term includes a transmitter only, a receiver only, or both a transmitter and a receiver together. In the case of a transducer and receiver together, the term includes physical or functional combinations, or separate devices that operate together as if they were physically or functionally combined.
There may be one or more transmitter/receiver. Each may perform independently of the other, such as the case where one serves as the backup to the other. However, if independent transmitter/receivers disagree as to the presence, location, or extent of a stroke, it is necessary to ignore one of them (for whatever reason, such as additional data gathered from another source), or to employ some other technique for resolving the disagreement. For example, one could require that they agree with each other, either completely or within some “confidence level” or other way of designating agreement, otherwise a stroke is not detected.
In a more advanced design, the signals from multiple transmitter/receivers may be coordinated together to provide a more robust diagnosis. For example, the image areas of two transmitter/receivers can be arranged to overlap and form a larger image area than either could provide alone. (The overlapping coverage of two automotive headlights is a common analogy.) This may lead to a situation in which “disagreement” between transmitter/receivers is expected. For example, a first transmitter/receiver may detect a stroke in an area outside the view of a second transmitter/receiver. The second unit should not also indicate a stroke (a so-called “false positive”) unless it is detecting a separate location of damage to the brain. However, if the first transmitter/receiver detects a stroke within the common area, and the second transmitter/receiver does not indicate a stroke, some other way to resolve the conflict must be used, as indicated before.
Each transmitter/receiver can be placed in any number of locations on the patient's head, including (a) natural openings in the skull, (b) man-made openings in the skull; and (c) known acoustic windows in the skull (some of which are also natural openings but some of which are regions where the skull is relatively thin but not open naturally).
In the case of a transmitter/receiver that is mounted adjacent a natural opening in the patient's skull, the typical locations are the ocular openings (i.e., the eye sockets or orbits), the nasal openings, and the aural openings. Man-made openings can be made in any convenient location using techniques known to neurosurgeons such as drilling a hole, removing a plate-shaped portion of skull, etc. It is optionally possible to use equipment designed to attach to the skull and provide a support for instruments. For example, the fixed base and movable/lockable ball-and-socket approach disclosed in International Publication Number WO 98/51229 (International Patent Application Number PCT/US98/51229) could be modified to accommodate a transducer/receiver instead of catheters.
Known acoustic windows include those known to clinicians as the anterior temporal window, the posterior temporal window, the middle temporal window, the transorbital window, the lateral frontal window, the paramedian frontal window, and the suboccipital foramen magnum window.
Ultrasonic systems produce or detect signals better if a transmitter/receiver is “acoustically coupled” in the vicinity of the natural or man-made opening, thus reducing signal loss due to reflection and dissipation when the ultrasonic waves strike (from either direction) the surface of the tissue immediately within the opening. Often it is sufficient for the transmitter/receiver to fit tightly within the opening and physically contact the tissue surface (or the surface of other tissue which itself is acoustically coupled to the tissue of interest).
The apparatus may improve the acoustic coupling if a tight fit is not present. This includes any way of moving or pushing the transmitter/receiver into greater contact with the opening, or with the tissue itself, or both. For example, a vacuum subsystem could be used to pull the transmitter/receiver toward the opening or the tissue. Or, a motor and linkage could be used to push the transducer/receiver toward the opening or the tissue. Or, an electronic or software-based correction could be made as part of the imaging process. Of course, combinations of any two or more of these examples (or other approaches) could be used.
In other embodiments, to improve the quality of the acoustic coupling (and maintain sterile conditions), an optional “acoustic coupling material” may be located between the transmitter/receiver and either the opening, the tissue, or both. Several such materials are already known, such as mineral oil, glycerin, propylene glycol, water and water-based gels. Acoustic coupling material may be used alone or together with any suitable subsystem to improve acoustic coupling.
In an even more specific arrangement, the actual degree or quality of the acoustic coupling is determined, and the image of the brain is modified to account for that determination. This could involve, for example, basing the determination of the type of stroke, in part, on the degree or quality of the acoustic coupling. In the specific case in which an acoustic coupling material is used, the degree or quality of the acoustic coupling could be taken to be the same as, or in some manner related to, the amount of acoustic coupling material present.
There are several embodiments of the invention that differ only in the manner in which the acoustic coupling material is used. The acoustic coupling material can be inserted into or removed from the apparatus. For example, a hole or other opening may allow the material to be inserted into its proper location. The positioning of the material could be done manually, or automatically by dispensing the acoustic coupling material into position between the ultrasonic transmitter/receiver and the opening in the skull. Optionally, the acoustic coupling material may be within (or otherwise supported by) a disposable piece that can be either manually or automatically inserted into or removed from the apparatus. Other embodiments would also include those in which the acoustic coupling material is received into position between the ultrasonic transmitter/receiver and the opening in the skull. The apparatus could have some type of feature to ensure that the disposable piece containing the acoustic coupling material fits into the apparatus only in a certain position or orientation. In another example, the apparatus, the disposable piece, or both could have features to ensure that the disposable piece containing the acoustic coupling material is used only once.
A variation on this theme involves preventing the proper operation of the invention unless a sufficient degree or quality of acoustic coupling is present. For example, either the invention is “locked out” because it detects that acoustic coupling is not present, or the apparatus is locked out unless some minimum sufficient amount of coupling is present. (Again, these conditions of acoustic coupling could be correlated with the actual quantity of acoustic coupling material, if such material is used.) One way of locking out the apparatus is to prevent imaging in the absence of sufficient acoustic coupling. Another way of accomplishing the same result is for the apparatus to enable imaging only in the presence of sufficient acoustic coupling. Any form of mechanical, electrical chemical, software-based, or other lockout technique is suitable.
A higher level of complexity is “closed loop” control of the degree or quality of the acoustic coupling (which could be the control of the amount of acoustic coupling material) based on image quality. That is, if the apparatus detects a degree of acoustic coupling that is near the adequate amount, the apparatus adjusts itself to improve the acoustic coupling. This could, for example, mean automatically increasing the amount of vacuum, or increasing the amount of acoustic coupling material by transferring the proper amount from some reservoir within (or adjacent to but under the control of) the apparatus.
In any embodiment, the transmitter/receiver should be held in its acoustically coupled position while transmitting or receiving ultrasonic waves. Because this is not always possible, the various embodiments of the invention use the technique of “dynamic coupling” to maintain or improve the ability of the invention to diagnose stroke in real time.
For example, dynamic coupling could be done by permitting the transmitter/receiver to move, but automatically detecting the amount and direction of such motion (in any convenient manner) and using such information for either of two purposes (or for some combination of the two). In either purpose, the motion of the transmitter/receiver does not reduce the ability to diagnose stroke; in fact, it may improve that ability.
The first purpose is to simply move the transmitter/receiver back to its original location, a subprocess known as “stabilization” for purposes of this invention. This subprocess is passive in the sense that it assumes that returning the transducer/receiver back to its former position is all that is needed under the circumstances.
The second purpose is to compensate for changes in the ultrasonic signal (either the transmitter signal or the echoed signal), if any, caused by the motion. This second purpose may involve actually moving the transducer/receiver, or it may involve modification of the imaging process, or some combination of the two. The second purpose is accomplished in a subprocess known as “compensation” for purposes of this invention. This subprocess is active in the sense that the quality of diagnosis determines the extent of motion of the transducer/receiver, or the type or amount of image modification, or both.
The vacuum system described above in the context of acoustic coupling is one preferred component of the dynamic coupling subsystem. In one embodiment, a platform defining one or more suction ports is positioned adjacent the opening in the skull. The platform is held to the patient by applying suction to at least one suction port. The ultrasonic transmitter/receiver is supported by the platform. Thus, by dynamically controlling the amount and location (in the case of multiple independent suction ports) of the vacuum, the transmitter/receiver is dynamically stabilized. Preferred configurations of this embodiment are suitable for curved, oval or circular openings: the platform forms a curved, oval, or circular arc so that the platform surrounds at least a portion of the opening. Even more preferred is a platform having at least two portions, each of which is shaped in at least a portion of the curve, oval, or circle, and arranged on generally opposite sides of the opening. Even more portions are possible, and such multi-portion embodiments permit greater control over the dynamic coupling technique.
Instead of a vacuum-based subsystem (or working together with it), actuators of any suitable type may be used to either improve the acoustic coupling, or to move the transmitter/receiver.
Another technique of dynamic coupling combines multiple diagnostic techniques for purposes of improving the overall value of the diagnosis. For example, any embodiment described above that employs ultrasonic imaging may be combined with any other technique for diagnosis of stroke. Data from the non-ultrasound technique can then be used to modify the image from the ultrasound transducer/receiver, or the diagnosis based on that image. Similarly, an overall diagnosis may be made using any combination of individual results from each technique. Suitable non-ultrasonic diagnostic methods include, but are not limited to: computed tomography (“CT”) scanning; magnetic resonance (“MR”) scanning; differential spectrophotometric methods, near-infrared detection of tissue characteristics; detection or measurement of certain biological materials or chemicals (e.g., the enzyme known as S100β), which could be done by any convenient method, including use of miniature silicon electronic biological assays (“lab-on-a-chip”) and techniques; detection of changes such as blood pressure, pressure within the eye, blood flow in the arteries serving organs other than the brain (such as those serving the eye), etc. For convenience, the apparatus used in a non-ultrasonic diagnostic technique is also referred to as a transducer/receiver below, because functions analogous to those of an ultrasonic transducer/receiver are also being performed.
In any embodiment, the invention may be adapted into a portable version suitable for use by first responders, paramedics and other field medical personnel. This involves modifications such as portable power supplies (e.g., single use or rechargeable batteries); or equipping the invention with suitable telemedicine features such as wireless transmission of data, on-board or remote data storage, etc.; or equipping the invention with features such as self-check diagnostics, alphanumeric or graphical displays of menus, commands, or other information, and the like.
Some versions of the invention are combinations of separate transducer units that mount in vacuum coupler units and are connected to image processor units. Others are unified or integrated combinations, such as a helmet-based unit in which the transducer, vacuum units, and image processors are all mounted on the helmet.
In any embodiment, image processing may include the use of expert systems, neural networks, or both.
In any embodiment, the invention may be adapted to for use in surgical suites. For example, the invention may be employed during or after cardiac surgery to detect strokes that are known to occur as complications in a small number of such cases.
In any embodiment, the invention may be employed to additionally deliver ultrasonic energy during the administration of therapy, such as tPA, in response to a diagnosis of stroke, so that the ultrasonic energy may improve the effectiveness of the therapy.
The drawings are schematic representations only. They are not intended to show all specific details discussed below, or those that might be included in a commercial version of any such embodiment. Features shown in one or more Figures could be combined, even if they are not illustrated together in a single FIGURE.
The following description is not intended to limit the technological or legal scope of the invention. For example, examples of various embodiments of the invention are only aids to understanding the features, functions, and benefits of the invention in its broadest sense.
In any event, actuator 7 may improve the diagnosis in a closed feedback and control loop. In this regard, it should be emphasized that
In general, imager 9 performs any process for identifying data relevant to the diagnosis of stroke. This includes techniques for automatically detecting symptoms based on any relevant criteria. The imaging may be qualitative or quantitative in nature and/or the manner in which it is reported. For example, imager 9 may execute an algorithm for scanning the brain to identify potentially likely symptoms of stroke, then analyze such regions in greater detail using one or more techniques. In doing so, it may perform digital calculations related to the diagnosis of stroke and transmit relevant data to a remote location for full diagnosis and/or confirmation using telemedicine techniques. Yet, in the vicinity of the patient, the result of the calculation may be reported in only a simpler “stroke/no stroke” manner, such as a display which is colored red for adequate perfusion and blue for inadequate perfusion, however quantitative the basis for determining adequacy of perfusion may be.
An optional, non-ultrasonic, detection of symptoms of stroke, illustrated schematically as 10, may also be used confirm, modify, or reject a diagnosis of stroke; as an input to the dynamic coupling of transducer 6 to the patient 4; or as input to the imaging process.
An optional wired or wireless communication link 11 may be used to transmit any form or content of data to another location, for any purpose. This would include any manner of reporting the results of the diagnosis as described above, or any other relevant information about the status of the system, the patient, etc.
Within the patient's brain 19 are several portions of cerebral vasculature that are imaged by the invention to diagnose stroke in the patient 4. Artery 13 is blocked by blockage 14 and thus the flow of blood downstream is inadequate. This is an example of ischemic stroke. Artery 15 is partially blocked by partial blockage 16 and thus the flow of blood downstream is diffused by the partial blockage and may be detected accordingly. (Typical whole or partial blockages are plaque, emboli, and the like.) By contrast, artery 17 is not blocked at all, but it has burst and thus diffuse blood flow 18 is present outside the vasculature and may be detected accordingly. This is an example of hemorrhagic stroke. Of course, these descriptions are for ease of illustration and should not be taken as limitations on the usual and well-understood medical description of the various types of stroke and the mechanisms that cause them. In any event, transducer 6 is used to diagnose any or all of these conditions in the patient in accordance with the principles of the invention.
Of course, the use of multiple locations in the manner just described is not limited to only the transducer designs illustrated in
While the above description is in terms of diagnosis of stroke, it should be noted that any embodiment of the invention could be used in a two-step regimen in which the patient is first diagnosed with stroke, and then additional ultrasonic energy is delivered (perhaps at different frequency, power level and the like) during administration of a therapy such as tPA.
Some embodiments of the invention employ modified or unmodified aspects of otherwise known ultrasonic diagnostic systems. Such systems include those commercially available from, or under development by: Sonosite, Pie Medical, Esaote, the Bracco Group, Philips Medical Systems, ATL, Hewlett-Packard, Agilent Technologies, Toshiba, Toshiba Medical Systems, Toshiba America Medical Systems, General Electric, General Electric Medical Systems, EchoCath, Acuson, Endosonics, Aloka, Hitachi Siemens Medical Systems, Inc., 3D Echotech, Ecton, SPECS USA, Daum, and Multigon Industries.
Some embodiments of the invention employ modified or unmodified aspects of otherwise known non-ultrasonic diagnostic systems. Such systems include those commercially available from, or under development by: Non-Invasive Technology, Baylor College of Medicine; the Center for Innovative Minimally Invasive Therapy (CIMIT) of Massachusetts (including its member organizations such as Massachusetts General Hospital, Brigham and Women's Hospital, Draper Laboratory, and Massachusetts Institute of Technology); Harvard Medical School;
The invention may be implemented using standard or custom ultrasonic transducers, transmitters/receivers, image generation equipment, etc., by adapting such devices as appropriate to accomplish the objectives described above.
Suitable stabilization devices can be made by modifying existing cardiac tissue stabilizers, such as any of the inventions described and claimed in:
Suitable vacuum-based stabilization devices can be made by modifying existing commercially available vacuum-based cardiac tissue stabilizers. Examples include the Medtronic Octopus®, Octopus2®, and Octopus®2+Tissue Stabilization Systems, or any similar product.
Suitable vacuum-based stabilization devices can be made by modifying known vacuum-based cardiac tissue stabilizers such as any of the inventions described or claimed in:
Other suitable stabilization devices can be made by modifying existing vacuum-based eye tissue stabilizers such as
Any known algorithms for detecting emboli or other aspects of blood flow can be used, including those described in the documents in the Appendix, and also:
The systems and methods employed in any known ultrasonic system may be adapted for use in embodiments of the invention. Such systems include those disclosed and claimed in the references in the Appendix, and especially the following:
Based on this disclosure, there are several improvements to the invention that are clearly desirable and already understood by the inventors to be within the legal scope of the invention. In general, this includes any improvement, currently known or later discovered, in areas such as portable electronics, ultrasonic imaging systems, computer graphics, signal processing, stroke diagnosis and treatment, and the like, that is suitable for use with the invention.
Such improvements specially include those that do not depend for their function, operation, or success on the specific medical condition and diagnostic techniques this invention relies upon. In other words, improvements to any similar device that is not the invention could and should be applied to the invention, as appropriate.
Examples of improvements within the currently understood scope of the invention include:
Improved ergonomic design, such as improvement in the fit to the patient, ease of use by the operator, or any type of adaptation to a harsh or otherwise specialized operating environment.
Provided they lie within the scope of the claims below, or are considered equivalent under the law, the legal scope of the invention includes any improvements or changes of the types described above, even if they are developed after the date of this document.
The full disclosure of each of the following documents is incorporated into this document.
All books, articles, documents, publications, U.S. Patents, U.S. Patent Applications, and International Patent Applications cited elsewhere in this document.
The following medical textbooks:
The following engineering and medical literature:
The following U.S. Pat. Nos. 6,135,961; 6,111,816; 6,106,472; 6,086,537; 6,056,691; 6,004,270; 5,976,088; 5,975,081; 5,970,025; 5,967,991; 5,967,991; 5,964,709; 5,961,462; 5,957,846; 5,954,675; 5,954,053; 5,940,123; 5,938,607; 5,935,071; 5,924,988; 5,922,945; 5,921,928; 5,919,138; 5,919,137; 5,917,190; 5,916,168; 5,904,652; 5,903,516; 5,899,865; 5,897,851; 5,897,498; 5,893,363; 5,893,363; 5,891,035; 5,879,303; 5,879,303; 5,873,821; 5,860,924; 5,855,556; 5,853,370; 5,851,186; 5,839,442; 5,837,900; 5,833,613; 5,827,969; 5,820,558; 5,817,024; 5,817,024; 5,807,263; 5,800,356; 5,795,297; 5,792,051; 5,782,769; 5,782,769; 5,782,755; 5,779,631; 5,770,823; 5,770,801; 5,769,079; 5,768,939; 5,762,067; 5,752,517; 5,729,508; 5,722,412; 5,722,412; 5,720,710; 5,720,708; 5,720,291; 5,718,229; 5,715,823; 5,713,362; 5,713,362; 5,707,607; 5,707,606; 5,690,114; 5,673,701; 5,669,388; 5,669,388; 5,669,385; 5,664,574; 5,660,909; 5,655,539; 5,648,942; 5,647,364; 5,645,066; 5,640,960; 5,636,631; 5,635,619; 5,634,466; 5,634,465; 5,630,418; 5,617,863; 5,606,972; 5,603,323; 5,596,987; 5,595,723; 5,590,658; 5,582,176; 5,573,751; 5,568,384; 5,562,098; 5,558,855; 5,558,853; 5,558,094; 5,555,887; 5,553,614; 5,546,946; 5,540,230; 5,540,230; 5,529,070; 5,517,994; 5,494,038; 5,492,134; 5,492,121; 5,488,953; 5,485,842; 5,482,047; 5,482,045; 5,479,930; 5,476,097; 5,474,073; 5,471,990; 5,471,989; 5,456,257; 5,450,851; 5,438,994; 5,425,370; 5,425,370; 5,421,336; 5,409,688; 5,409,005; 5,402,793; 5,402,778; 5,390,675; 5,390,674; 5,386,827; 5,381,795; 5,373,845; 5,373,845; 5,373,845; 5,365,929; 5,353,799; 5,348,015; 5,343,865; 5,343,865; 5,343,865; 5,329,927; 5,329,927; 5,329,927; 5,305,756; 5,295,485; 5,295,307; 5,287,753; 5,255,682; 5,233,994; 5,226,422; 5,226,420; 5,215,094; 5,207,225; 5,197,477; 5,187,672; 5,167,230; 5,161,536; 5,158,088; 5,123,415; 5,122,974; 5,119,815; 5,103,827; 5,099,847; 5,095,910; 5,081,995; 5,076,278; 5,076,278; 5,062,428; 5,050,610; 5,016,641; 4,975,892; 4,975,723; 4,972,331; 4,926,871; 4,887,306; 4,883,059; 4,829,430; 4,817,618; 4,800,317; 4,691,418; 4,670,339; 4,658,827; 4,657,895; 4,644,795; 4,607,642; 4,603,702; 4,581,636; 4,567,895; 4,543,960; 4,542,653; 4,508,122; 4,508,122; 4,431,006; 4,430,898; 4,417,582; 4,411,360; 4,407,294; 4,399,704; 4,392,486; 4,354,502; 4,341,222; 4,298,009; 4,298,009; 4,282,880; 4,282,755; 4,282,577; 4,277,979; 4,258,576; 4,249,539; 4,237,902; 4,233,989; 4,222,274; 4,197,751; 4,197,749; 4,168,628; 4,165,182; 4,153,894; 4,131,024; 4,035,822; 4,019,818; 3,997,717; 3,978,508; 3,969,578; 3,953,822.
The following numbered aspects of the invention are part of the original disclosure of this invention. They are written as if they were individual inventions, so that they may be specifically considered as such in subsequent applications. Thus, some of the following may duplicate the claims at the end of this application. Some of them may contain additional limitations than those claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3948248||Sep 5, 1974||Apr 6, 1976||Zuckerman Joel L||Method of measuring ocular pulse|
|US4237901||Aug 30, 1978||Dec 9, 1980||Picker Corporation||Low and constant pressure transducer probe for ultrasonic diagnostic system|
|US4575799 *||Mar 23, 1983||Mar 11, 1986||Fujitsu Limited||Ultrasonic living body tissue characterization system|
|US4692139||Sep 30, 1985||Sep 8, 1987||Stiles Frank B||Catheter for effecting removal of obstructions from a biological duct|
|US4951653 *||Mar 2, 1988||Aug 28, 1990||Laboratory Equipment, Corp.||Ultrasound brain lesioning system|
|US5058592 *||Nov 2, 1990||Oct 22, 1991||Whisler G Douglas||Adjustable mountable doppler ultrasound transducer device|
|US5247938||Jan 11, 1990||Sep 28, 1993||University Of Washington||Method and apparatus for determining the motility of a region in the human body|
|US5379770 *||Dec 21, 1993||Jan 10, 1995||Nicolet Biomedical, Inc.||Method and apparatus for transcranial doppler sonography|
|US5388583||Sep 1, 1993||Feb 14, 1995||Uab Vittamed||Method and apparatus for non-invasively deriving and indicating of dynamic characteristics of the human and animal intracranial media|
|US5409005 *||Oct 7, 1993||Apr 25, 1995||Medasonics, Inc.||Transcranial doppler probe wheel and track/bar fixation assembly|
|US5471988 *||Dec 23, 1994||Dec 5, 1995||Olympus Optical Co., Ltd.||Ultrasonic diagnosis and therapy system in which focusing point of therapeutic ultrasonic wave is locked at predetermined position within observation ultrasonic scanning range|
|US5477858||Jul 9, 1991||Dec 26, 1995||Siemens Medical Systems, Inc.||Ultrasound blood flow/tissue imaging system|
|US5503152||Sep 28, 1994||Apr 2, 1996||Tetrad Corporation||Ultrasonic transducer assembly and method for three-dimensional imaging|
|US5509896||Sep 9, 1994||Apr 23, 1996||Coraje, Inc.||Enhancement of thrombolysis with external ultrasound|
|US5690117||Mar 20, 1995||Nov 25, 1997||Gilbert; John W.||Ultrasonic-fiberoptic imaging ventricular catheter|
|US5695460||May 15, 1995||Dec 9, 1997||Coraje, Inc.||Enhancement of ultrasound thrombolysis|
|US5919144||May 6, 1997||Jul 6, 1999||Active Signal Technologies, Inc.||Apparatus and method for measurement of intracranial pressure with lower frequencies of acoustic signal|
|US5951477||Sep 11, 1997||Sep 14, 1999||Uab Vittamed||Method and apparatus for determining the pressure inside the brain|
|US6019724||Feb 8, 1996||Feb 1, 2000||Gronningsaeter; Aage||Method for ultrasound guidance during clinical procedures|
|US6027460||Sep 14, 1995||Feb 22, 2000||Shturman Cardiology Systems, Inc.||Rotatable intravascular apparatus|
|US6066097||Oct 22, 1997||May 23, 2000||Florida Atlantic University||Two dimensional ultrasonic scanning system and method|
|US6196972 *||Nov 11, 1998||Mar 6, 2001||Spentech, Inc.||Doppler ultrasound method and apparatus for monitoring blood flow|
|US6197345||Nov 8, 1999||Mar 6, 2001||The Board Of Regents Of The University Of Nebraska||Thrombolytic agents and methods of treatment for thrombosis|
|US6328694||May 26, 2000||Dec 11, 2001||Inta-Medics, Ltd||Ultrasound apparatus and method for tissue resonance analysis|
|US6390982 *||Jul 21, 2000||May 21, 2002||Univ Florida||Ultrasonic guidance of target structures for medical procedures|
|US6398772||Mar 26, 1999||Jun 4, 2002||Coraje, Inc.||Method and apparatus for emergency treatment of patients experiencing a thrombotic vascular occlusion|
|US6454757||Sep 2, 1999||Sep 24, 2002||Advanced Cardiovascular Systems, Inc.||Ultrasonic method for ablating and removing obstructive matter from anatomical passageways and blood vessels|
|US6468219 *||Apr 24, 2000||Oct 22, 2002||Philip Chidi Njemanze||Implantable telemetric transcranial doppler device|
|US6682483 *||May 26, 2000||Jan 27, 2004||Vuesonix Sensors, Inc.||Device and method for mapping and tracking blood flow and determining parameters of blood flow|
|US6682502||Nov 2, 2001||Jan 27, 2004||Transon, Llc||Apparatus for emergency treatment of patients experiencing a thrombotic vascular occlusion|
|US6733451||Mar 25, 2003||May 11, 2004||Omnisonics Medical Technologies, Inc.||Apparatus and method for an ultrasonic probe used with a pharmacological agent|
|US6929632||Jun 27, 2002||Aug 16, 2005||Advanced Cardiovascular Systems, Inc.||Ultrasonic devices and methods for ablating and removing obstructive matter from anatomical passageways and blood vessels|
|US6945937||Sep 3, 2004||Sep 20, 2005||Board Of Trustees University Of Arkansas||Ultrasound apparatus and method for augmented clot lysis|
|US6985771||Jan 22, 2002||Jan 10, 2006||Angel Medical Systems, Inc.||Rapid response system for the detection and treatment of cardiac events|
|US20020198469 *||Mar 12, 2002||Dec 26, 2002||Keith Bridger||Brain assessment monitor|
|1||Abstracts, Journal of Neuroimaging, 1997, vol. 7, pp. 229-230.|
|2||Akiyama, M., et al., "Low-Frequency Ultrasound Penetrates the Cranium and Enhances Thrombolysis in Vitro," Neurosurgery, vol. 43, No. 4, Oct. 1998, pp. 828-833.|
|3||Alexandrov, A., et al., "High Rate of Complete Recanalization and Dramatic Clinical Recovery During tPA Infusion When Continuously Monitored With 2-MHz Transcranial Doppler Monitoring," Stroke, 2000;31;610-614; downloaded from stroke.ahajournals.org on Jun. 5, 2007.|
|4||Alexandrov, A.V., et al., "Transcranial Doppler: An Overview of its Clinical Applications," Journal of Emergency and Intensive Care Medicine, 2000, vol. 4, No. 1.|
|5||*||Andrei V. Alexandrov and Matthew Joseph, Transcranial Doppler: An Overview of its Clinical Applications, Journal of Emergency and Intensive Care Medicine, 2000, vol. 4, No. 1.|
|6||Becker, G., et al., "Transcranial Color-Coded Real-Time Sonography of Intracranial Veins," Journal of Neuroimaging, vol. 5, No. 2, Apr. 1995, pp. 87-94.|
|7||Luo, H., et al., "Thrombolysis: Transcutaneous Ultrasound Augments Lysis of Arterial Thrombi in Vivo," Circulation, vol. 94(4), Aug. 15, 1996, pp. 775-778.|
|8||Martin, P. J., et al., "Color-Coded Ultrasound Diagnosis of Vascular Occlusion in Acute Ischemic Stroke," Journal of Neuroimaging, vol. 5, No. 3, Jul. 1995, pp. 152-156.|
|9||Nabavi, D., et al., "Diagnostic Benefit of Echocontrast Enhancement for the Insufficient Transtemporal Bone Window," Journal of Neuroimaging, vol. 9, No. 2, Apr. 1999, pp. 102-107.|
|10||Olsson, S. B., et al., "Enhancement of Thrombolysis by Ultrasound," Ultrasound in Med. & Biol., vol. 20, No. 4, pp. 375-382, 1994.|
|11||Ries, F., "Clinical Experience with Echo-Enhanced Transcranial Doppler and Duplex Imaging," Journal of Neuroimaging, Suppl. 1, to vol. 7., Apr. 1997, pp. S15-S21.|
|12||Seidel, G., et al., "Harmonic Grey Scale Imaging of the Human Brain," Journal of Neuroimaging, vol. 9, No. 3, Jul. 1999, pp. 171-174.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8840558||Jun 4, 2009||Sep 23, 2014||Starkey Laboratories, Inc.||Method and apparatus for mathematically characterizing ear canal geometry|
|US9433373 *||Jun 4, 2010||Sep 6, 2016||Starkey Laboratories, Inc.||Method and apparatus for mathematically characterizing ear canal geometry|
|US9457201 *||May 10, 2013||Oct 4, 2016||The Regents Of The University Of California||Portable device to initiate and monitor treatment of stroke victims in the field|
|US20090306517 *||Jun 4, 2009||Dec 10, 2009||Starkey Laboratories, Inc.||Method and apparatus for mathematically characterizing ear canal geometry|
|US20100160779 *||Aug 3, 2007||Jun 24, 2010||Koninklijke Philips Electronics N.V.||Ultrasound system for cerebral blood flow imaging and microbubble-enhanced blood clot lysis|
|US20100312533 *||Jun 4, 2010||Dec 9, 2010||Starkey Laboratories, Inc.||Method and apparatus for mathematically characterizing ear canal geometry|
|US20110205031 *||Feb 25, 2011||Aug 25, 2011||Nihon Kohden Corporation||Remote maintenance system and relay unit|
|US20140194740 *||Nov 1, 2013||Jul 10, 2014||Cerebrosonics, Llc||Emboli detection in the brain using a transcranial doppler photoacoustic device capable of vasculature and perfusion measurement|
|USRE46049 *||Aug 8, 2011||Jul 5, 2016||Koninklijke Philips Electronics N.V.||Automatic external defibrillator for the diagnosis of stroke|
|WO2014031824A2 *||Aug 22, 2013||Feb 27, 2014||Elwha Llc||Adaptive ultrasonic array|
|WO2014031824A3 *||Aug 22, 2013||Apr 17, 2014||Elwha Llc||Adaptive ultrasonic array|
|WO2014031871A2 *||Aug 22, 2013||Feb 27, 2014||Elwha Llc||Adaptive ultrasonic array|
|WO2014031871A3 *||Aug 22, 2013||Apr 17, 2014||Elwha Llc||Adaptive ultrasonic array|
|U.S. Classification||600/454, 600/465, 600/437, 600/451, 600/468, 600/443|
|International Classification||A61B8/14, A61B8/00|
|Cooperative Classification||A61B5/026, G01S15/8993, A61B6/501, A61B8/4281, A61B8/0808, A61B8/481, G01S7/52036, A61B6/5247, A61N7/00, Y10S128/92, A61B5/02438, A61B8/06, A61B8/4416, A61B5/6834, A61B5/4076|
|European Classification||A61B8/06, A61B8/08D, A61B5/68B3F, A61B8/42F2, A61B8/44F|
|Jun 27, 2007||AS||Assignment|
Owner name: KONINKLIJKE PHILIPS ELECTRONICS N.V., NETHERLANDS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIPTON, DAVID;FORREST, PETER;SIGNING DATES FROM 20070601TO 20070604;REEL/FRAME:019554/0694
|Dec 13, 2013||REMI||Maintenance fee reminder mailed|
|Apr 28, 2014||FPAY||Fee payment|
Year of fee payment: 8
|Apr 28, 2014||SULP||Surcharge for late payment|
Year of fee payment: 7